# High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer

> **NCT00002837** · PHASE1,PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 21 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** Filgrastim (G-CSF)
- **DRUG:** Cyclophosphamide
- **DRUG:** Doxorubicin Hydrochloride
- **DRUG:** Paclitaxel
- **PROCEDURE:** Peripheral Blood Stem Cell Transplantation

## Key facts

- **NCT ID:** NCT00002837
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-09
- **Primary completion:** 2002-01
- **Final completion:** 2002-01
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2012-07-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002837, "High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00002837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*